146 related articles for article (PubMed ID: 8801748)
1. [Long-term results of iodine radioisotope therapy for lung metastasis of thyroid cancer].
Tsyb AF; Drozdovskiĭ BI; Proshin VV
Vopr Onkol; 1996; 42(3):73-5. PubMed ID: 8801748
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of distant iodine-negative metastases of thyroid cancer with 32P].
Drozdovskiĭ BI; Proshin VV
Vopr Onkol; 1996; 42(3):71-2. PubMed ID: 8801747
[TBL] [Abstract][Full Text] [Related]
3. 131I dosimetry and thyroid stunning.
Gerard SK; Park HM
J Nucl Med; 2003 Dec; 44(12):2039-40; author reply 2040. PubMed ID: 14660731
[No Abstract] [Full Text] [Related]
4. [Determining the activities of 131I with dose-rate constraint method for the treatment of differentiated thyroid carcinoma with diffuse pulmonary metastases].
Liu B; Zeng Y; Wang JT; Zhao Z; Mu D; Kuang AR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 May; 41(3):513-7. PubMed ID: 20629335
[TBL] [Abstract][Full Text] [Related]
5. [Metabolic therapy with radioiodine of differentiated thyroid tumor].
Bestagno M; Campagnari G
Minerva Med; 1986 Nov; 77(44):2113-6. PubMed ID: 3785727
[No Abstract] [Full Text] [Related]
6. [Metastases of a medullary carcinoma of the thyroid (follicular variant). Diagnosis and therapy using radioiodine].
Ruhlmann J; Vogel J; Bockisch A; Biersack HJ
Dtsch Med Wochenschr; 1987 Jul; 112(30):1170-2. PubMed ID: 3608841
[TBL] [Abstract][Full Text] [Related]
7. Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approach.
Dorn R; Kopp J; Vogt H; Heidenreich P; Carroll RG; Gulec SA
J Nucl Med; 2003 Mar; 44(3):451-6. PubMed ID: 12621014
[TBL] [Abstract][Full Text] [Related]
8. Hierarchy of treatment variables affecting outcome of 131I therapy in thyroid cancer patients with lung metastases.
Kozak OV; Sukach GG; Korchinskaya OI; Trembach AM; Turicina VL; Voit NU
Exp Oncol; 2005 Jun; 27(2):150-5. PubMed ID: 15995635
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of distant metastases of thyroid cancer using 131I].
Drozdovskiĭ BIa; Proshin VV
Med Radiol (Mosk); 1986 Jul; 31(7):18-20. PubMed ID: 3736381
[No Abstract] [Full Text] [Related]
10. [Effective focal doses and the radiation loads in the radioiodine therapy of thyroid cancer].
Ivanitskaia VI; Shantyr' VI; Pudovkina LF; Kozhukhov VD
Med Radiol (Mosk); 1981 Nov; 26(11):6-12. PubMed ID: 7332697
[No Abstract] [Full Text] [Related]
11. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients.
Dottorini ME; Vignati A; Mazzucchelli L; Lomuscio G; Colombo L
J Nucl Med; 1997 May; 38(5):669-75. PubMed ID: 9170425
[TBL] [Abstract][Full Text] [Related]
12. [Lungs absorbed dose in radioiodine therapy of differentiated thyroid carcinoma with diffuse pulmonary metastases].
Liu B; Zeng Y; Wang J; Zhao Z; Mu D; Kuang A
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Aug; 27(4):851-4. PubMed ID: 20842858
[TBL] [Abstract][Full Text] [Related]
13. [Radioiodide therapy in pulmonary metastasis of differentiated thyroid cancer--factors affecting the success of I-131 therapy].
Takada Y; Ohta Y; Kawasaki S; Maki M; Hiroe M; Kusakabe K; Shigeta A; Yamazaki T; Fujimoto Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Jul; 47(7):962-70. PubMed ID: 3658666
[No Abstract] [Full Text] [Related]
14. Radioiodine therapy in differentiated thyroid carcinoma.
Salvatori M; Rufini V; Garganese MC; Di Giuda D
Rays; 2000; 25(2):221-38. PubMed ID: 11370540
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients.
Samaan NA; Schultz PN; Haynie TP; Ordonez NG
J Clin Endocrinol Metab; 1985 Feb; 60(2):376-80. PubMed ID: 3965495
[TBL] [Abstract][Full Text] [Related]
16. [Radiation therapy of remote metastases from thyroid cancer].
Kiseleva ES; Falileeva EP
Med Radiol (Mosk); 1971 Feb; 16(2):27-37. PubMed ID: 5173489
[No Abstract] [Full Text] [Related]
17. Cumulative doses of adjunct 131I treatment depend on location of residual thyroid tissue after total thyroidectomy in differentiated thyroid cancer.
Saint-Vil D; Emran MA; Lambert R; Alos N; Turpin S; Huot C
J Pediatr Surg; 2007 May; 42(5):853-6. PubMed ID: 17502198
[TBL] [Abstract][Full Text] [Related]
18. Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group.
La Quaglia MP; Black T; Holcomb GW; Sklar C; Azizkhan RG; Haase GM; Newman KD
J Pediatr Surg; 2000 Jun; 35(6):955-9; discussion 960. PubMed ID: 10873043
[TBL] [Abstract][Full Text] [Related]
19. [Combined treatment of thyroid cancer metastases to the lungs in children and young people].
Kiseleva ES; Skorobogatov NM; Zvekotkina LS; Voronetskiĭ IB
Med Radiol (Mosk); 1987 Mar; 32(3):7-10. PubMed ID: 3561214
[TBL] [Abstract][Full Text] [Related]
20. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
